Global Transdermal Preparation Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Transdermal Preparation Market Research Report 2024
A transdermal preparation, which may also be considered a Transdermal Drug Delivery System (TDDS), is defined as a flexible, multi-layered, pharmaceutical single dose preparation of varying size containing one or more active substances to be applied to the intact skin for systemic absorption.
According to Mr Accuracy reports new survey, global Transdermal Preparation market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Transdermal Preparation market research.
Key manufacturers engaged in the Transdermal Preparation industry include Viatris, ERCO Pharma, MEDRx, Novartis, GSK, 4P Therapeutics, Transdermal Corporation, Medpharm and Nitto, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Transdermal Preparation were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Transdermal Preparation market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Preparation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Viatris
ERCO Pharma
MEDRx
Novartis
GSK
4P Therapeutics
Transdermal Corporation
Medpharm
Nitto
Hunan Jiudian Pharmaceutical
Beijing Tide Pharmaceutical
Luye Pharma Group
Guangzhou Continent Biomedical Technology
Harbin Hexinotai Pharmaceutical Technology
Demo Technology
Novastage Pharmaceuticals (Shenzhen)
Segment by Type
Injectable Preparations
Non Injectable Preparations
Hospital
Clinic
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Transdermal Preparation report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Transdermal Preparation market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Transdermal Preparation market research.
Key manufacturers engaged in the Transdermal Preparation industry include Viatris, ERCO Pharma, MEDRx, Novartis, GSK, 4P Therapeutics, Transdermal Corporation, Medpharm and Nitto, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Transdermal Preparation were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Transdermal Preparation market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Preparation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Viatris
ERCO Pharma
MEDRx
Novartis
GSK
4P Therapeutics
Transdermal Corporation
Medpharm
Nitto
Hunan Jiudian Pharmaceutical
Beijing Tide Pharmaceutical
Luye Pharma Group
Guangzhou Continent Biomedical Technology
Harbin Hexinotai Pharmaceutical Technology
Demo Technology
Novastage Pharmaceuticals (Shenzhen)
Segment by Type
Injectable Preparations
Non Injectable Preparations
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Transdermal Preparation report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices